Women need to be aware of changes, breast expert says
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, reported today that the FDA has accepted Vanda’s resubmission of the iloperidone New Drug Application (NDA). Vanda’s resubmission was a Complete Response to the not approvable action letter that the company received on July
Full Post: FDA accepts Vanda Pharmaceuticals Iloperidone resubmission
Every day, women face a barrage of headlines about breast cancer. What should they do with all of that information?
George Sledge, M.D., an internationally recognized breast cancer expert, pointed out that, despite all of the near-constant news and information about breast cancer, it is not the disease that impacts most women.
“It’s important to know that, while breast cancer is a common cancer, it is not the most common cause of death in American women. Heart disease is far more common. Women need not be paralyzed by the prospect of breast cancer.”
Overall, the American Cancer Society says a woman has about a one in eight chance of developing breast cancer during her lifetime. There will be 182,460 new cases of breast cancer in the United States in 2008.
Dr. Sledge, Ballve-Lantero Professor at the Indiana University School of Medicine and an oncologist and researcher at the Indiana University Melvin and Bren Simon Cancer Center, said women need to be knowledgeable - not overwhelmed - about steps they should take regarding their breasts.
For starters, women should undergo regular screening mammography, beginning at age 40.
“Fortunately, a great majority of women today are diagnosed with what we consider early-stage disease,” Sledge said. “That’s been a trend in recent years because of screening mammography.”
Other than mammography, women need to pay attention to their bodies. “Women need to be aware of change in their breasts,” Sledge added. “If they notice a lump, mass, or a new area of tenderness that they haven’t noticed before, they should get that checked out promptly.”
- A woman should know about her family history. A woman is at greater risk of developing breast cancer if she has one of the following:
- A personal history of breast, ovarian, or colon cancer
- A close relative who was diagnosed with breast cancer before menopause or in both breasts
Never had children or who had her first child after age 30
Once detected, breast cancer is usually treated by both local therapy and systemic therapy.
In local therapy, the goal is to eliminate the cancer in the breast and the related lymph nodes and minimize the risk of recurrence.
Treatment options include surgery - breast preservation, lumpectomy (removes only the breast lump and surrounding tissue), or mastectomy (removal of all breast tissue) - and radiation therapy.
Systemic therapy involves eliminating tumor cells that might have escaped into the circulation and minimizing the risk of developing distant sites of tumor growth. Treatment options include chemotherapy, hormonal therapy, and newer and an ever-expanding class of agents known as biological therapy.
“We live in an era where we have far more to offer women with breast cancer than ever before,” Sledge said. “We live in an era where our ability to screen for breast cancer has gotten better than ever before. We live in an era where there’s the prospect for new diagnostic and therapeutic technology for breast cancer.”
A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman’s hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. Results will be presented at the annual meeting of the Radiological Society of
Full Post: Positron emission mammography effective in detecting breast cancer
The revelation that champion marathon runner Kerryn McCann did nothing for months after discovering a lump in her breast, is a stark warning to women to heed any changes they notice in their breasts and seek medical advice. According to the National Breast and Ovarian Cancer Centre (NBOCC), the dual Commonwealth marathon gold medallist and
Full Post: Untimely death of Kerryn McCann a stark warning
Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M. D. Anderson Cancer Center will report at the 31st at the CRTC-AACR San Antonio Breast Cancer Symposium. MRI is known to be more sensitive in detecting breast
Full Post: Magnetic resonance imaging alternated with mammography may be best for high-risk women
A dual-headed dedicated gamma camera used during molecular breast imaging (MBI) can accurately detect small breast tumors less than 2 cm in size, according to a study performed at the Mayo Clinic in Rochester, MN. One-hundred fifty patients who had suspicious lesions smaller than 2 cm in size were imaged using dual-head molecular breast imaging.
Full Post: Dual-headed dedicated gamma camera accurately detects small breast tumors
Mammography and sonography findings help doctors identify and appropriately treat breast cancer in men, according to a study performed at the University of Texas M.D. Cancer Center in Houston, TX. Image findings from 57 male patients who were diagnosed with breast cancer were reviewed during the study. “The findings show that breast cancer in men
Full Post: Male breast cancer